When rheumatology meets hepatology: Are anti-TNFs safe in hepatitis B virus carriers?

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Jansen, Tim L ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS DNA; BIOLOGICAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC INFLAMMATION; CLINICAL ARTICLE; DATA ANALYSIS; DRUG SAFETY; EDITORIAL; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MEDICAL RECORD; NONHUMAN; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SEROLOGY; SPONDYLOARTHROPATHY; VIRUS INFECTION; DRUG ANTAGONISM; DRUG EFFECT; HETEROZYGOTE; LIVER; NOTE;

ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; CARRIER STATE; HEPATITIS B; HUMANS; LIVER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955474755     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2899     Document Type: Editorial

References (9)

1. Charpin C, Guis S, Colson P, Borentain P, Mattéi JP, Alcaraz P, Balandraud N, Thomachot B, Roudier J, Gérolami R. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients. Arthritis Res Ther 2009, 11:R179. 10.1186/ar2868, 19941642.
2. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. Effect of leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 1976, 295:517-522.
3. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006, 355:704-712. 10.1056/NEJMct055183, 16914706.
4. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007, 45:1056-1075. 10.1002/hep.21627, 17393513.
5. Dienstag JL, Isselbacher KJ. Acute viral hepatitis. Harrison's Principles of Internal Medicine 2005, 2:1822-1838. New York: McGraw-Hill, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, 16.
6. Manno M, Cammà C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004, 127:756-763. 10.1053/j.gastro.2004.06.021, 15362032.
7. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982, 96:447-449.
8. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology 1991, 100:182-188.
9. Raftery G. Chronic viral hepatitis and TNF blockade. Rheumatology (Oxford) 2007, 46:1381. 10.1093/rheumatology/kem082, 17567635.